You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Slovakia

May 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

Consumer health in Slovakia grows in 2011 despite poor economic situation

Consumers’ budgets came increasingly under pressure in 2011 due to a number of factors, ranging from strict austerity measures which increased the VAT rate from 19% to 20% and a rise in most excise taxes. The increasing cost of living of Slovak households placed more strain on consumers’ wallets as Slovakia recorded one of the highest inflation levels recorded within EU member states. Combined with the increasing unemployment, only OTC consumer health recorded stable growth in current value terms and marginally exceeded inflation in 2011.

Legislative change redefines the Slovak public healthcare system

Doctors in Slovakia are no longer prescribing drugs, instead only prescribing the active ingredient, while the pharmacist chooses the appropriate drug as his duty is to suggest the cheapest product available to cure a disease. In 2011, the Slovak government also adopted new rules defining prices for healthcare products which ranked Slovakia second for offering the second cheapest consumer health products within the EU member states. These are only several of the more extensive legislative changes which dramatically redefined public healthcare in Slovakia in 2011.

Competition intensifies as Slovakia adopts new rules

Competition within consumer health in Slovakia intensified, mostly for external factors. Companies now have to monitor prices in detail as pharmacists are obliged to offer the cheapest solutions for consumers (while they can suggest more expensive variants and let the consumer decide). Sales agents are no longer allowed to visit doctors during ordination hours. Any discounts offered to the consumer have become more expensive as companies or pharmacies now have to give a 50% discount for that particular product to the health insurance company as well. The already harsh competitive environment is likely to further intensify in 2012 as promotion of some OTC products is in jeopardy.

Chemists/pharmacies retains leading position in 2011

Chemists/pharmacies continued to be the major channel in consumer health, being responsible for more than three quarters of total sales. Only a limited assortment of products can be found outside of pharmacies, particularly in supermarkets, hypermarkets and convenience stores. While channels other than chemists/pharmacies strengthen, particularly internet retailing as online pharmacies started operating in 2009, the liberalisation of OTC consumer health in Slovakia is nowhere in sight. Only a very limited number of goods can be therefore sold outside of pharmacies.

Constant growth for consumer health over forecast period is imminent but will face many constraints

The future outlook for consumer health continues to be positive but not as bright as in the past. The latest changes in legislation which dictate prices of drugs, medicinal equipment and accessories lowered prices of some products at the end of the review period. Nonetheless, consumers will continue to increase expenditure on disease prevention and educate themselves which should lead to the strengthening of OTC sales at the expense of prescription drugs (Rx).


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Slovakia with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Slovakia, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Slovakia for free:

The Consumer Health in Slovakia market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Slovakia?
  • What are the major brands in Slovakia?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Slovakia - Industry Overview

EXECUTIVE SUMMARY

Consumer health in Slovakia grows in 2011 despite poor economic situation

Legislative change redefines the Slovak public healthcare system

Competition intensifies as Slovakia adopts new rules

Chemists/pharmacies retains leading position in 2011

Constant growth for consumer health over forecast period is imminent but will face many constraints

KEY TRENDS AND DEVELOPMENTS

OTC sales grow in spite of unfavourable economic conditions

All major players strengthen their positions in 2011

Private label and availability of consumer health in grocery retailers remain limited

Interest towards self-medication and prevention is on the rise

Legislative changes dramatically change healthcare in Slovakia

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Penetration of Private Label by Category 2006-2011
  • Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

  • Summary 1 OTC - Switches 2011 (from OTC to Rx)

DEFINITIONS

SOURCES

  • Summary 2 Research Sources

Consumer Health in Slovakia - Company Profiles

Edenpharma sro in Consumer Health (Slovakia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Generica spol sro in Consumer Health (Slovakia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 5 Generica spol sro: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 6 Generica spol sro: Competitive Position 2011

Krka dd Novo Mesto in Consumer Health (Slovakia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 8 Krka dd Novo Mesto: Competitive Position 2011

Walmark spol sro in Consumer Health (Slovakia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 10 Walmark spol sro: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 11 Walmark spol sro: Competitive Position 2011

Zentiva as in Consumer Health (Slovakia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 14 Zentiva as: Competitive Position 2011

Adult Mouth Care in Slovakia - Category Analysis

HEADLINES

TRENDS

  • Adult mouth care grew by 2% in total current value terms to total sales of EUR2.5 million in 2011. The category experienced problems in the last two years of the review period, because of strong competition between players due to the financial crisis and from oral care products. Many consumers find those products sufficient and feel that adult mouth care is only needed when moderate health problems occur. Another point of comparison is lack of marketing for adult mouth care; compared to strong and complex promotions for mouthwashes in the country.

SWITCHES

COMPETITIVE LANDSCAPE

  • Within adult mouth care in Slovakia, Medicom International sro led value sales with 26% share in 2011. Medicom´s success is the result of the strong marketing promotion of its product Tantum Verde Spray which is well-known among Slovak consumers.

PROSPECTS

  • Adult mouth care is expected to decline by a 1% constant value CAGR over the forecast period. The decline is expected mainly because of strong competition from widely available traditional oral care products. In the time of financial crisis, Slovak consumers prefer the more traditional oral care products which are cheaper such as mouthwashes. This is also the main potential forecast threat.

CATEGORY DATA

  • Table 12 Sales of Adult Mouth Care: Value 2006-2011
  • Table 13 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 14 Adult Mouth Care Company Shares by Value 2007-2011
  • Table 15 Adult Mouth Care Brand Shares by Value 2008-2011
  • Table 16 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 17 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Slovakia - Category Analysis

HEADLINES

TRENDS

  • Analgesics belongs among the biggest and most dynamic categories of Slovakian consumer health, being the third biggest category in terms of current value sales. Analgesics grew by 2% in current value terms to reach EUR29 million in 2011. Slovakia strictly follows the EU guidelines on OTC drugs classification while the State Institute for Drug Control (SUKL) is maintaining a case specific point of view on product classification. For example, even though many analgesics containing acetaminophen can be found over-the- counter, those with higher content can be purchased based on a doctor’s prescription.

SWITCHES

COMPETITIVE LANDSCAPE

  • Analgesics in Slovakia is traditionally the domain of Zentiva which dominated the category in 2011 holding a 59% value share. It owns popular brands such as Ibalgin and Paralen which alone held a combined value share of 33%. Zentiva was followed by Reckitt Benckiser Slovak Republic spol sro and GlaxoSmithKline Slovakia sro which held value shares of 7% and 6% respectively in 2011.

PROSPECTS

  • Analgesics is expected to grow by a constant CAGR of 2% over the forecast period to reach total constant value sales of EUR32.1 million in 2016. This growth will be the consequence of hectic lifestyles and growing interest in self-medication. Even though the vast majority of consumers will continue to buy the products they know and are used to, it is likely that some consumers will switch to cheaper brands as more generic products are expected to be launched over the forecast period. The lower unit price for such products will hamper the value growth potential for analgesics.

CATEGORY DATA

  • Table 18 Sales of Analgesics by Category: Value 2006-2011
  • Table 19 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 20 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011
  • Table 21 Analgesics Company Shares by Value 2007-2011
  • Table 22 Analgesics Brand Shares by Value 2008-2011
  • Table 23 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 24 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Slovakia - Category Analysis

HEADLINES

TRENDS

  • Calming and sleeping grew by 5% to total value sales of EUR3.1 million in 2011 as everyday stress is very common and these products popular with people. Consumers prefer herbal/traditional calming and sleeping due to the fact that these products are not addictive and do not have any side effects.

SWITCHES

COMPETITIVE LANDSCAPE

  • Sandoz Slovensko dd is the ultimate category leader holding 55% retail value share in 2011. The company is successful due to its well-established brands. None of the producers recorded significant decline or growth in their value share.

PROSPECTS

  • Price competition between the brands present will continue to place pressure on constant price growth. Sales will also be under the influence of weaker demand for OTC products such as calming and sleeping and is expected to record a drop in volume sales by 3% over the forecast period. Consumers with ongoing sleeping disorders are increasingly seeking advice of a doctor/specialist and switch to prescription therapy instead of staying loyal to OTC brands.

CATEGORY DATA

  • Table 25 Sales of Calming and Sleeping: Value 2006-2011
  • Table 26 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 27 Calming and Sleeping Company Shares by Value 2007-2011
  • Table 28 Calming and Sleeping Brand Shares by Value 2008-2011
  • Table 29 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 30 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Slovakia - Category Analysis

HEADLINES

TRENDS

  • Cough, cold and allergy (hay fever) remedies witnessed remarkable current value growth at 6% in 2011 representing a jump of EUR3 million. The performance was driven by the weather conditions – a cold winter, rapid temperature changes throughout the year and both a colder and shorter summer period. Consumers’ desire for self-medication played a key role in this as did their approach to health complications. Slovaks are not as sensitive to the prices of products when they face adverse and unpleasant health complications, as they are elsewhere.

SWITCHES

COMPETITIVE LANDSCAPE

  • GlaxoSmithKline Slovakia sro led cough, cold and allergy (hay fever) remedies with 17% value share in 2011, followed by Reckitt Benckiser with 11%. Zentiva ranked third with 7% value share. When looking at the brands, the ranking is very similar with Coldres (by GlaxoSmithKline) leading, followed by Strepsils (by Reckitt Benckiser) and Septolete (by the Slovenian Krka dd Novo Mesto).

PROSPECTS

  • Cough, cold and allergy (hay fever) remedies is expected to grow by a constant value CAGR of 2% over the forecast period. The category will benefit from a low percentage of vaccinated population as well as growing perception. Only a minor increase in unit prices is expected to take place in the near future, due to the fact that the landscape is highly competitive and because of the legislative pressure to keep prices as low as possible.

CATEGORY DATA

  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 32 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 33 Sales of Decongestants by Category: Value 2006-2011
  • Table 34 Sales of Decongestants by Category: % Value Growth 2006-2011
  • Table 35 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 36 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011
  • Table 38 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 40 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Slovakia - Category Analysis

HEADLINES

TRENDS

  • Digestive remedies grew by 4% to total EUR20 million in current value sales. The combination of bad eating habits, the lack of exercise and stressful life of consumers are the sources of many digestive problems. Many consumers have to buy OTC products and use them daily to avoid digestive ailments. These facts drove sales of digestive remedies in 2011.

SWITCHES

COMPETITIVE LANDSCAPE

  • Zentiva as led the category in 2011 with a retail value share of 30% due to its well promoted strategy and large product portfolio that includes popular brands such as Pancrealon Forte and Endiaron which are also the top two products in digestive remedies with combined value share of 22%. Their other products are also well-known among consumers, such as Orenzym, Isochol or Febichol. The company also witnessed the biggest increased in value share, gaining 1.5 percentage points in 2011.

PROSPECTS

  • Digestive remedies is expected to grow by a 1% constant value CAGR over the forecast period. The category has a stable growth rate each year and this trend is not expected to change a lot during the beginning of the forecast period but will then wane towards end of the forecast period as the market gets more saturated.

CATEGORY DATA

  • Table 41 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 42 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 43 Digestive Remedies Company Shares by Value 2007-2011
  • Table 44 Digestive Remedies Brand Shares by Value 2008-2011
  • Table 45 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 46 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Slovakia - Category Analysis

HEADLINES

TRENDS

  • Until 2000, ear care was present in Slovakian consumer health with overall sales of only EUR40,000. During the following ten years, awareness of ear care consistently increased, as consumers started to pay more attention to and look after their ears properly, as they care for other parts of their body. In 2011, ear care grew by 1% in current value terms.

SWITCHES

COMPETITIVE LANDSCAPE

  • Ear care brands are produced by both domestic and international manufacturers. Domestic company Vyskumny Ustav Lieciv Modra (brand Instillatio) continued to lead sales in 2011 with 73% retail value share. Ranked second was French producer Laboratoires Diepharmex SA with 27% retail value share; this company recorded the fastest growth and gained three percentage points in the category compared to 2009 due to strong marketing promotion of its brand Audispray.

PROSPECTS

  • Over the forecast period, ear care is expected to decline in constant value sales terms by a 2% CAGR. This will be driven mostly by the growing emphasis on self-medication in Slovakia. Consumers will increasingly seek a pharmacist’s advice for minor ear problems, rather than visit a doctor.

CATEGORY DATA

  • Table 47 Sales of Ear Care: Value 2006-2011
  • Table 48 Sales of Ear Care: % Value Growth 2006-2011
  • Table 49 Ear Care Company Shares by Value 2007-2011
  • Table 50 Ear Care Brand Shares by Value 2008-2011
  • Table 51 Forecast Sales of Ear Care: Value 2011-2016
  • Table 52 Forecast Sales of Ear Care: % Value Growth 2011-2016

Emergency Contraception in Slovakia - Category Analysis

HEADLINES

TRENDS

  • Emergency contraception grew by 9% in current value terms to reach sales of EUR60,000 in 2011. Escapelle was the only product present at the end of the review period, as it is intended only for exceptional and urgent cases and should not be used as a regular method of contraception. An overall decrease in value growth was evident each year as a result of changing lifestyles of females. In general emergency contraception is considered a last resort for many women as such medication has the potential to damage one’s health.

COMPETITIVE LANDSCAPE

  • Gedeon Richter Slovakia sro with its brand Escapelle was the only non-prescription product available in Slovakia at the end of the review period. The company promotes its product in health magazines and on the internet as no competition is present and no other promotion is needed. Information about Escapelle can be also obtained by women from their gynaecologist, who will explain how to attain and use Escapelle when needed.

PROSPECTS

  • The continuation of decreasing sales will be present over the forecast period. In 2012, emergency contraception is expected to grow by 3% in constant value terms but then decline after that. This situation could change the arrival of new products which could impress with promotions targeting women, lower retail price and attractive packaging which are also the main threats.

CATEGORY DATA

  • Table 53 Sales of Emergency Contraception: Value 2006-2011
  • Table 54 Sales of Emergency Contraception: % Value Growth 2006-2011
  • Table 55 Emergency Contraception Company Shares by Value 2007-2011
  • Table 56 Emergency Contraception Brand Shares by Value 2008-2011
  • Table 57 Forecast Sales of Emergency Contraception: Value 2011-2016
  • Table 58 Forecast Sales of Emergency Contraception: % Value Growth 2011-2016

Eye Care in Slovakia - Category Analysis

HEADLINES

TRENDS

  • Eye care recorded 2% growth in current value sales to total EUR1.9 million in 2011. With consumers spending a great deal more time in front of televisions or computer screens, busy lifestyles with only a few hours sleep and no time to visit a doctor for prevention, or when minor problems with eyes appear, are the main reasons for increasing eye care sales. Both allergy and standard eye care displayed current value growth of 2% in 2011.

SWITCHES

COMPETITIVE LANDSCAPE

  • Two companies held the leading positions within ear care in Slovakia. Teva Pharmaceuticals Slovakia sro led the category with 33% retail value share, with many products available such as Ophtalmo-Septonex, which is well-known and popular among consumers. Unimed Pharma is the second largest company present with 31% value share. Pfizer Luxembourg Sarl oz ranked third in 2011 generating most of its sales from its brand Visine which was the most sold product among brands with a value share of 17%.

PROSPECTS

  • Eye care sales benefit from the stressful lifestyles of consumers which are not expected to change over the years to come. However, eye care is expected to record a slight decrease over the forecast period both in volume and value terms dropping by nearly 2%. The reasons for the decline are high prices and the irresponsibility of people who do not treat eye problems with eye care products when needed, but go to see a doctor later when more serious problems appear; by then other treatments, in many cases even operations are then necessary.

CATEGORY DATA

  • Table 59 Sales of Eye Care by Category: Value 2006-2011
  • Table 60 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 61 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 62 Standard Eye Care by Positioning: % Value Breakdown 2007-2011
  • Table 63 Eye Care Company Shares by Value 2007-2011
  • Table 64 Eye Care Brand Shares by Value 2008-2011
  • Table 65 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 66 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Slovakia - Category Analysis

HEADLINES

TRENDS

  • Herbal/traditional products remained popular among Slovak consumers due to its perceived safety, but the growth slowed down due to the poor economic situation in the country and consumers preferred to save more money. Herbal/traditional products increased by just 1% in current value terms, with sales reaching EUR21 million in 2011.

COMPETITIVE LANDSCAPE

  • Krewel Meuselbach GmbH led herbal/traditional products with 12% value share in 2011 due to its large amount of products offered to customers. Only minor increases/decreases in company sales were witnessed in 2011, because there are many players present and with exception of Krewel Meuselbach, their value sales were no higher than 10%.

PROSPECTS

  • Herbal/traditional products in Slovakia is expected to stagnate over the forecast period and until 2016 to gain no more than 1% in constant value terms. The main reasons for this stagnation are linked to the expansion of private label product portfolios of major retailers, as well as the entry of new brands, which will impact price competition and so likely result in the decline of retail prices of herbal/traditional products.

CATEGORY DATA

  • Table 67 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 68 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 69 Herbal/Traditional Products Company Shares 2007-2011
  • Table 70 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 71 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 72 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Slovakia - Category Analysis

HEADLINES

TRENDS

  • The hectic lifestyle of consumers with poor eating habits and worsening environment are the main reasons for various skin infections. Slovak consumers are very sensitive about their skin problems and pay more attention to prevention. Therefore, medicated skin care is becoming more popular each year. In 2011, it grew by 2% with overall current value sales reaching EUR13.3 million.

SWITCHES

COMPETITIVE LANDSCAPE

  • Novartis Slovakia sro led medicated skin care with 13% retail value share in 2011. The competition within medicated skin care is intense as the top three companies hold only 31% value share. There are nine companies present here with value share over 5%. There were also minor changes in the increase/decrease of company sales in 2011.

PROSPECTS

  • Medicated skin care is expected to witness a constant value CAGR of -1% over the forecast period. This decline in value sales growth will be a result of producers’ correlative competition, as new brands might appeal to consumers not only via healing effects but also via retail price and marketing promotions.

CATEGORY DATA

  • Table 73 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 74 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 75 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 76 Medicated Skin Care Brand Shares by Value 2008-2011
  • Table 77 Hair Loss Treatments Brand Shares by Value 2008-2011
  • Table 78 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 79 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Slovakia - Category Analysis

HEADLINES

TRENDS

  • NRT smoking cessation aids stagnated in current value terms to total sales of EUR300, 000 in 2011. Many Slovak consumers tend to stop smoking, mainly because of health or financial problems. However, NRT smoking cessation aids is not a very popular product in Slovakia due to high prices and consumers in most cases do not believe that it could help them. They would rather try some alternative methods instead, such as going outside for a walk or run, or eating some fruit or sweets. This is the main reason behind the stagnation.

SWITCHES

COMPETITIVE LANDSCAPE

  • Pfizer Luxembourg Sarl oz remained as a dominant leader with 90% retail value share with Nicorette, which is best available for consumers with all the favourite flavours: fresh mint, original and fresh fruit. A strong promotional and advertising support of this brand is the key factor of success. The company also gained the most value share with four percentage points in 2011.

PROSPECTS

  • Stagnation is expected to change to downturn, with a constant value CAGR of -3% over the forecast period. The reason for this situation is the high prices of NRT smoking products and the competition from other, alternative products as stated above which are also the main threats to this category.

CATEGORY INDICATORS

  • Table 80 Number of Smokers by Gender 2006-2011

CATEGORY DATA

  • Table 81 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2011
  • Table 82 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2011
  • Table 83 NRT Gum Flavours: % Value Breakdown 2006-2011
  • Table 84 NRT Smoking Cessation Aids Company Shares by Value 2007-2011
  • Table 85 NRT Smoking Cessation Aids Brand Shares by Value 2008-2011
  • Table 86 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
  • Table 87 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016

Sports Nutrition in Slovakia - Category Analysis

HEADLINES

TRENDS

  • Sports nutrition recorded stagnation in current value terms in 2011 to reach sales of EUR2.4 million. A continuation of 2010’s stagnation continued. Innovation of new products or moderately lower unit prices could change this trend.

COMPETITIVE LANDSCAPE

  • Weider Global Nutrition LLC led sales with a current value share of 23% in 2011. The company is one of the longest running retailers for sports nutrition in Slovakia and offers products that consumers favour.

PROSPECTS

  • Sports nutrition is expected to see a -2% constant value CAGR over the forecast period. Non-protein products could decline even more with a -3% constant value CAGR during that period. This significant slowdown of value sales will be achieved by changing lifestyles of consumers and increased interest for health and wellness principles in their everyday lives.

CATEGORY DATA

  • Summary 15 Dietary Supplements: Brand Ranking by Positioning 2011
  • Table 88 Sales of Sports Nutrition: Value 2006-2011
  • Table 89 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 90 Sports Nutrition Company Shares 2007-2011
  • Table 91 Sports Nutrition Brand Shares 2008-2011
  • Table 92 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 93 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Slovakia - Category Analysis

HEADLINES

TRENDS

  • Vitamins and dietary supplements remained very popular in Slovakia, even with high prices. These products are the best way of prevention to many illnesses and regular use has can also provide curative effects. Therefore, the category witnessed stable yearly growth.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Walmark spol sro led overall vitamins and dietary supplements with 28% retail value share in 2011, gaining half a percentage point from the previous year. The company has longstanding experience to give consumers products that they need. It also promotes its products in television adverts, magazines and frequent product innovations.

PROSPECTS

  • Vitamins and dietary supplements in Slovakia are expensive and the economic situation in the country could have a negative effect on sales. Therefore, the category is predicted to record a constant value CAGR of 1% over the forecast period.

CATEGORY DATA

  • Summary 16 Dietary Supplements: Brand Ranking by Positioning 2011
  • Table 94 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 95 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 96 Dietary Supplements by Positioning 2006-2011
  • Table 97 Vitamins and Dietary Supplements Company Shares by Value 2007-2011
  • Table 98 Vitamins and Dietary Supplements Brand Shares by Value 2008-2011
  • Table 99 Vitamins Brand Shares by Value 2008-2011
  • Table 100 Dietary Supplements Brand Shares by Value 2008-2011
  • Table 101 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 102 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016

Weight Management in Slovakia - Category Analysis

HEADLINES

TRENDS

  • Weight management in Slovakia is losing sales, because consumers still prefer to follow a healthier lifestyle. This leads to the fact that consumers do not need these types of products and would rather spend their money on fortified/functional foods and beverages. Weight management increased by 5% in current value terms in 2011, which was only half of the review period CAGR.

COMPETITIVE LANDSCAPE

  • Walmark spol sro led sales of weight management with a value share of 30% in 2011. Its products such as Clarinol or Viaredin are well-known and popular among Slovak consumers as they have high marketability.

PROSPECTS

  • Weight management is predicted to decline sharply in constant value terms by 10% in 2012, to then calm down to experience positive growth for the remainder of the forecast period; however, this poor early result in 2012 will be enough to affect the category’s performance which will see marginal decline as a whole. This will be the result of changing consumer lifestyles as they will spend their money more on health and wellness food and beverages.

CATEGORY DATA

  • Table 103 Sales of Weight Management: Value 2006-2011
  • Table 104 Sales of Weight Management: % Value Growth 2006-2011
  • Table 105 Weight Management Company Shares 2007-2011
  • Table 106 Weight Management Brand Shares 2008-2011
  • Table 107 Forecast Sales of Weight Management: Value 2011-2016
  • Table 108 Forecast Sales of Weight Management: % Value Growth 2011-2016

Wound Care in Slovakia - Category Analysis

HEADLINES

TRENDS

  • Wound care grew by 2% to reach sales of EUR2.7 million in current value terms in 2011. Stable growth was recorded each year because of legislative changes to first aid kits which took effect in 2010. Thus, first aid kits was the fastest growing segment with current value increase of 3%. No new technologies or delivery formats were introduced in 2011.

COMPETITIVE LANDSCAPE

  • Wound care is led by Hartmann-Rico sro with 60% retail value share. The success of the company is achieved due to the full coverage of overall wound care and wide distribution via the majority of important retail channels in the country. The company experienced success due to its business strategy and also witnessed the biggest increase in value share by gaining three percentage points.

PROSPECTS

  • Wound care is predicted to witness a constant value CAGR of -2%. In the past, the growth was driven by the fact that first aid kids recorded significant jumps in sales in 2010 and 2011 due to legislative changes. As the financial crisis forced consumers to save more money and no further legislative changes are prepared, wound care will lose sales. During this period, private label is expected to perform the best, because of lower prices.

CATEGORY DATA

  • Table 109 Sales of Wound Care by Category: Value 2006-2011
  • Table 110 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 111 Wound Care Company Shares by Value 2007-2011
  • Table 112 Wound Care Brand Shares by Value 2008-2011
  • Table 113 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 114 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Aloe
            • Guarana
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Lecithin
            • Other Other Non-Herbal Dietary Supplements
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Paediatric Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Paediatric Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Paediatric Consumer Health
      • Paediatric Analgesics
        • Paediatric Acetaminophen
        • Paediatric Aspirin
        • Paediatric Combination Products - Analgesics
        • Paediatric Diclofenac
        • Paediatric Dipyrone
        • Paediatric Ibuprofen
        • Paediatric Ketoprofen
        • Paediatric Naproxen
      • Paediatric Cough, Cold and Allergy Remedies
        • Paediatric Allergy Remedies
        • Paediatric Cough/Cold Remedies
      • Paediatric Digestive Remedies
        • Paediatric Diarrhoeal Remedies
        • Paediatric Indigestion and Heartburn Remedies
        • Paediatric Laxatives
        • Paediatric Motion Sickness Remedies
      • Paediatric Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Paediatric Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!